The Rome II and Rome III criteria identify the same subtype-populations in irritable bowel syndrome: Agreement depends on the method used for symptom report

Neurogastroenterology and Motility

Volumn 24, Issue 7, 2012, Pages

  Engsbro, A L ^a   Simren M ^b   Bytzer, P ^a  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Agreement; Classification; Epidemiology; Irritable bowel syndrome; Rome III criteria; Subtypes

Indexed keywords

PROBIOTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; INFORMATION PROCESSING; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; ROME II QUESTIONNAIRE; ROME III QUESTIONNAIRE;

FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84862642103     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01908.x     Document Type: Article

References (24)

1. Choung RS, Locke GR III. Epidemiology of IBS. Gastroenterol Clin North Am 2011; 40: 1-10.
2. Spiegel BM. The burden of IBS: looking at metrics. Curr Gastroenterol Rep 2009; 11: 265-9.
3. 'Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
4. Coletta M, Di PL, Tomba C et al. Discrepancy between recalled and recorded bowel habits in irritable bowel syndrome. Aliment Pharmacol Ther 2010; 32: 282-8.
5. Deiteren A, Camilleri M, Bharucha AE et al. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil 2010; 22: 415-23, e95.
6. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhea by simple clinical assessment of intestinal transit rate. BMJ 1990; 300: 439-40.
7. Törnblom H, Van Oudenhove L, Sadik R, Abrahamsson H, Tack J, Simrén M. Colonic transit time and IBS symptoms: what's the link? Am J Gastroenterol 2012; doi: 10.1038/ajg.2012.5.
8. Thompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders. In: Drossman DA, Corrazziari E, Talley N et al., eds. Rome II: The Functional Gastrointestinal Disorders Diagnosis, Pathophysiology and Treatment. A multinational Consensus. McLean, Virginia, USA: Degnon Associates, 2000: 351-432.
9. Longstreth GF. Definition and classification of irritable bowel syndrome: current consensus and controversies. Gastroenterol Clin North Am 2005; 34: 173-87.
10. Dorn SD, Morris CB, Hu Y et al. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol 2009; 43: 214-20.
11. Ersryd A, Posserud I, Abrahamsson H et al. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment Pharmacol Ther 2007; 26: 953-61.
12. Garrigues V, Mearin F, Badia X et al. Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study). Aliment Pharmacol Ther 2007; 25: 323-32.
13. Simren M, Ohman L, Olsson J et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study. Aliment Pharmacol Ther 2010; 31: 218-27.
14. Sondergaard B, Olsson J, Ohlson K et al. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand J Gastroenterol 2011; 46: 663-72.
15. Engsbro AL, Simren M, Bytzer P. Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification. Aliment Pharmacol Ther 2012; 35: 350-9.
16. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 920-4.
17. Altman DG. Practical Statistics for Medical Research, 1st edn. Florida: Chapman & Hall/CRC, 1991.
18. Palsson OS, Baggish JS, Turner MJ et al. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. Am J Gastroenterol 2012; 107: 286-95.
19. Mearin F, Baro E, Roset M et al. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 2004; 99: 113-21.
20. Halder SL, Locke GR III, Schleck CD et al. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 2007; 133: 799-807.
21. Drossman DA, Morris CB, Hu Y et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005; 128: 580-9.
22. Williams RE, Black CL, Kim HY et al. Stability of irritable bowel syndrome using a Rome II-based classification. Aliment Pharmacol Ther 2006; 23: 197-205.
23. Weinland SR, Morris CB, Hu Y et al. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment. Am J Gastroenterol 2011; 106: 1813-20.
24. Heitkemper M, Cain KC, Shulman R et al. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern. Dig Dis Sci 2011; 56: 2050-8.